Article
Metabolic Dysregulations and Epigenetics: A Bidirectional Interplay that Drives Tumor Progression
30 Jul 2019
Abstract excerpt
Cancer has been considered, for a long time, a genetic disease where mutations in keyregulatory genes drive tumor initiation, growth, metastasis, and drug resistance. Instead, theadvent of high-throughput technologies has revolutionized cancer research, allowing to investigatemolecular alterations at multiple levels, including genome, epigenome, transcriptome, proteome,and metabolome and showing the multifaceted...
Topics
Join the communities discussing this publication.